Related Experiment Video
Updated: Jun 28, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Species-specific interaction of Streptococcus pneumoniae with human complement factor H
Ling Lu1, Zhuo Ma, T Sakari Jokiranta
1Center for Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
Abstract:
Streptococcus pneumoniae naturally colonizes the nasopharynx as a commensal organism and sometimes causes infections in remote tissue sites. This bacterium is highly capable of resisting host innate immunity during nasopharyngeal colonization and disseminating infections. The ability to recruit complement factor H (FH) by S. pneumoniae has been implicated as a bacterial immune evasion mechanism against complement-mediated bacterial clearance because FH is a complement alternative pathway inhibitor. S. pneumoniae recruits FH through a previously defined FH binding domain of choline-binding protein A (CbpA), a major surface protein of S. pneumoniae. In this study, we show that CbpA binds to human FH, but not to the FH proteins of mouse and other animal species tested to date. Accordingly, deleting the FH binding domain of CbpA in strain D39 did not result in obvious change in the levels of pneumococcal bacteremia or virulence in a bacteremia mouse model. Furthermore, this species-specific pneumococcal interaction with FH was shown to occur in multiple pneumococcal isolates from the blood and cerebrospinal fluid. Finally, our phagocytosis experiments with human and mouse phagocytes and complement systems provide additional evidence to support our hypothesis that CbpA acts as a bacterial determinant for pneumococcal resistance to complement-mediated host defense in humans.
Insights
Streptococcus pneumoniae evades human immune defenses by using its CbpA protein to bind human complement factor H (FH). This interaction, specific to humans, helps the bacteria resist complement-mediated clearance, preventing bacterial clearance.
Area of Science:
- Microbiology
- Immunology
- Molecular Biology
Background:
- Streptococcus pneumoniae colonizes the nasopharynx and can cause invasive infections.
- Pneumococcal immune evasion involves resisting host innate immunity.
- Complement factor H (FH) inhibits the complement alternative pathway, aiding bacterial survival.
Purpose of the Study:
- To investigate the species-specific interaction between Streptococcus pneumoniae's CbpA and complement factor H.
- To determine the role of CbpA in pneumococcal resistance to host immune defenses.
Main Methods:
- Investigated CbpA binding to human and animal FH proteins.
- Utilized a mouse model to assess virulence of CbpA-mutated S. pneumoniae.
- Performed phagocytosis assays with human and mouse phagocytes and complement systems.
Main Results:
- CbpA specifically binds human FH, but not FH from other tested species.
- Deletion of the FH binding domain in CbpA did not alter pneumococcal bacteremia or virulence in mice.
- Species-specific FH interaction was observed in clinical pneumococcal isolates.
- Phagocytosis experiments confirmed CbpA's role in resisting human complement-mediated defense.
Conclusions:
- CbpA mediates species-specific binding of FH by Streptococcus pneumoniae.
- This interaction is a key mechanism for pneumococcal immune evasion in humans.
- CbpA is a determinant of pneumococcal resistance to human complement-mediated host defense.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
Related Concept Videos
Complement System
Determinants of Bacterial Pathogenicity and Virulence
Bacterial Meningitis II: Pathophysiology
Pneumonia I: Introduction
Streptococcal Pharyngitis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...